Detalhe da pesquisa
1.
Evidence of SARS-CoV-2 infection in postmortem lung, kidney, and liver samples, revealing cellular targets involved in COVID-19 pathogenesis.
Arch Virol;
168(3): 96, 2023 Feb 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36842152
2.
Potential mechanisms involved on how systemic IgG antibodies specific to vascular endothelial growth factor (VEGF) and induced by active immunotherapy decrease platelet derived free-VEGF.
Platelets;
33(7): 964-968, 2022 Oct 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35373709
3.
Specific humoral response in cancer patients treated with a VEGF-specific active immunotherapy procedure within a compassionate use program.
BMC Immunol;
21(1): 12, 2020 03 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32171254
4.
Systemic translation of locally infiltrated epidermal growth factor in diabetic lower extremity wounds.
Int Wound J;
16(6): 1294-1303, 2019 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31429187
5.
Characteristics of the specific humoral response in patients with advanced solid tumors after active immunotherapy with a VEGF vaccine, at different antigen doses and using two distinct adjuvants.
BMC Immunol;
18(1): 39, 2017 07 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28747172
6.
Indirect and competitive enzyme-linked immunosorbent assays for monitoring the humoral response against human VEGF.
J Immunoassay Immunochem;
37(6): 636-58, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27143151
7.
Comparative in vitro and experimental in vivo studies of the anti-epidermal growth factor receptor antibody nimotuzumab and its aglycosylated form produced in transgenic tobacco plants.
Plant Biotechnol J;
11(1): 53-65, 2013 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23046448
8.
A recombinant SARS-CoV-2 receptor-binding domain expressed in an engineered fungal strain of Thermothelomyces heterothallica induces a functional immune response in mice.
Vaccine;
40(8): 1162-1169, 2022 02 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35078661
9.
Chimeric Antigen by the Fusion of SARS-CoV-2 Receptor Binding Domain with the Extracellular Domain of Human CD154: A Promising Improved Vaccine Candidate.
Vaccines (Basel);
10(6)2022 Jun 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35746505
10.
Murine monoclonal antibodies against RBD of the SARS-CoV-2 spike protein as useful analytical tools for subunit vaccine development and clinical trials.
J Immunol Methods;
500: 113195, 2022 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34843713
11.
An engineered SARS-CoV-2 receptor-binding domain produced in Pichia pastoris as a candidate vaccine antigen.
N Biotechnol;
72: 11-21, 2022 Dec 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35953030
12.
Targeting the hydrophilic regions of recombinant proteins by MS via in-solution buffer-free trypsin digestion.
Eur J Mass Spectrom (Chichester);
26(3): 230-237, 2020 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31822129
13.
Does VEGF-targeted active immunotherapy induce complete abrogation of platelet VEGF levels?
BMC Res Notes;
12(1): 323, 2019 Jun 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31182141
14.
Anti-tumoral effect of active immunotherapy in C57BL/6 mice using a recombinant human VEGF protein as antigen and three chemically unrelated adjuvants.
Angiogenesis;
11(4): 381-93, 2008.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19034678
15.
Specific active immunotherapy with the HEBERSaVax VEGF-based cancer vaccine: From bench to bedside.
Semin Oncol;
45(1-2): 68-74, 2018 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30318086
16.
Evaluation of methodologies to determine the effect of specific active immunotherapy on VEGF levels in phase I clinical trial patients with advanced solid tumors.
Heliyon;
4(11): e00906, 2018 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30426104
17.
Specific humoral and cellular immune responses in cancer patients undergoing chronic immunization with a VEGF-based therapeutic vaccine.
Vaccine;
35(28): 3582-3590, 2017 06 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28536029
18.
Experimental studies of a vaccine formulation of recombinant human VEGF antigen with aluminum phosphate.
Hum Vaccin Immunother;
11(8): 2030-7, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25891359
19.
Péptido inmunomodulador CIGB-258 para el tratamiento de pacientes graves y críticos con la COVID-19 / An immunomodulatory peptide CIGB-258 for the treatment of critical and severe COVID-19 patients
Rev. cuba. med. mil;
49(4): e926, tab, graf
Artigo
em Espanhol
| LILACS
| ID: biblio-1156494
20.
Expression, purification and characterization of a recombinant fusion protein based on the human papillomavirus-16 E7 antigen.
Springerplus;
2(1): 12, 2013 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23483788